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Type 1 diabetesAims: Low-carbohydrate diet (LCD) has gained interest among individuals with diabetes as
a means to manage glycaemia. We investigated the adherence to LCD in the Finnish
Diabetic Nephropathy Study and whether carbohydrate restriction is associated with
cardio-metabolic risk factors.
Methods: Cross-sectional data were available from 902 individuals with type 1 diabetes (44%
men, age 47 ± 13 years). Dietary data were collected twice with a 3-day diet record. Mean of
the measurements was used. Carbohydrate intake <130 g/day or <26 E% was used as indi-
cation of LCD. Individuals reporting LCD were compared to sex-, diabetes duration- and
eGFR-matched controls with higher carbohydrate intakes (>253 g/day or >48 E%). In the
whole population, carbohydrate-to-fat ratio was calculated and its association with health
variables was investigated.
Results: Higher carbohydrate-to-fat ratio was associated with higher blood glucose variabil-
ity, higher blood pressure, lower HDL cholesterol concentration, and in men with lower
waist-to-hip ratio. LCD adherence (n = 69) was associated with lower BMI (25.6 vs.
27.8 kg/m2, p = 0.030), lower variability of blood glucose measurements (0.38 vs.
0.45 mmol/l, p = 0.030), and lower diastolic blood pressure (74 vs. 79 mmHg, p = 0.048).
Men reporting LCD had higher total (5.1 vs. 4.0 mmol/l, p = 0.007) and non-HDL cholesterol
(3.4 vs. 2.7 mmol/l, p = 0.021). Women with LCD had higher HDL-cholesterol concentration
(1.9 vs. 1.5 mmol/l, p = 0.014).
Conclusions: Reduced blood glucose variability, related to LCD, could have clinical relevance
to individuals with type 1 diabetes.
 2019 Elsevier B.V. All rights reserved.f Helsinki,
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Prior to the discovery of insulin, dietary carbohydrate restric-
tion was used as a method to manage blood glucose levels in
type 1 diabetes [1]. After the exogenous insulin became avail-
able, however, diets with carbohydrates as the predominant
macronutrient, became the standard of nutritional manage-
ment. While today, recommending a particular macronutri-
ent distribution is no longer officially enforced [2],
carbohydrates persistently continue to provide the majority
of dietary energy in the diets of individuals with type 1 dia-
betes [3,4]. Importantly, dietary carbohydrates contribute to
postprandial glycaemia, which is a major determinant of,
not only long-term glycaemia [5], but also of macrovascular
complications and mortality [6].
Carbohydrate counting and subsequent dosing of bolus
insulin, as taught in various education programmes such as
the Dose adjustment for normal eating (DAFNE) [7], are the
foundations of the modern nutritional management of type
1 diabetes. However, due to errors in estimating carbohydrate
contents of the meals [8], and variation in the absorption of
the injected insulin [9], reaching postprandial normogly-
caemia is often a challenge [10]. It is therefore not surprising
that suboptimal HbA1c levels are frequently reported among
individuals with type 1 diabetes [11].
Because of dissatisfaction with suboptimal glycaemic con-
trol related to the adherence to higher carbohydrate diets,
some individuals with diabetes have once again turned to car-
bohydrate restriction as a means to tackle glycaemia. While
most of the current observations have been from patients
with type 2 diabetes [12], also individuals with type 1 diabetes
may benefit from carbohydrate restriction as an adjunct to
insulin treatment. Unlike seen in the Diabetes Control and
Complications Trial where reduction in HbA1c, that followed
the intensification of insulin therapy, was burdened by con-
comitant increase in the risk of hypoglycaemia [13], such risk
has not been associatedwith improved glycaemia achieved by
carbohydrate restriction [14–16]. Instead, restricting dietary
carbohydrate intake has rather lead to lower variability in
the blood glucose levels [15,16].
Presuming unchanged energy requirement, reduction in
carbohydrate intake needs to be accompanied by an increase
in the intake of at least one other macronutrient. In practice,
this is often fat [17], as protein requirement mainly depends
on the urinary and faecal nitrogen loss, and protein required
for tissue growth [18]. This has raised concerns whether
adherence to such a high-fat diet would have negative conse-
quences for cardio-metabolic risk factors [19–21]. This study
was undertaken to explore the frequency of adhering to
low-carbohydrate diets in a sample of Finnish individuals
with type 1 diabetes. Additionally, our goal was to investigate
the association between low-carbohydrate diet and cardio-
vascular risk factors.
2. Methods
The study subjects, in this cross-sectional study, were partic-
ipants in the nation-wide multicentre Finnish Diabetic
Nephropathy (FinnDiane) Study. The aim of the FinnDianeStudy is to identify risk factors for diabetes complications in
adult (18 years) individuals with type 1 diabetes. Partici-
pants were recruited from over 80 centres around Finland
(see the electronic supplementary material for a list of the
centres). Type 1 diabetes was defined as diabetes onset before
the age of 40 years, and permanent insulin treatment, initi-
ated within a year from the diagnosis. Of the FinnDiane Study
participants, we included in the current analyses those who
had completed a diet record for a minimum of 3 days with
plausible energy intake [5020–14,600 kJ/d (1200–3500 kcal/d)],
whose estimated glomerular filtration rate (eGFR) was
60 ml/min/1.73 m2, andwho showed no signs of acute infec-
tion (high-sensitivity C-reactive protein, hsCRP, 10 mg/l).
The Ethics Committee of The Helsinki and Uusimaa Hospital
District approved the study protocol. The study was per-
formed in accordance with the ethical standards laid down
in the 1964 Declaration of Helsinki and its later amendments.
Written informed consent was obtained from all participants
upon study entry.
2.1. Variables and measurements
At the study visit the participants were thoroughly investi-
gated, as previously described [22]. In brief, the participants’
weight and height were measured in light clothing without
wearing shoes. Height was measured using a wall-mounted
stadiometer. Waist and hip circumferences were measured
using an inelastic tape measure. Waist circumference was
measured at the midway between the lowest rib and iliac
crest, while the hip circumference was measured with the
subject standing with feet close together, around the widest
portion with the tape measure parallel to the floor. Body mass
index (BMI; weight in kg/height in m2), waist-to-hip ratio
(waist circumference/hip circumference), and body adiposity
index (BAI; [hip circumference in cm/height in m1.5]  18)
were calculated. Following a minimum of ten-minute rest,
blood pressure was measured twice using a digital blood pres-
sure monitor (Omron M6, OMRON Healthcare UK Ltd, Milton
Keynes, UK). In case the two measurements differed by over
10 mmHg a third measurement was conducted, in which case
the two measurements closest to each others were used.
Mean of the two measurements was used in the analyses.
HbA1c was measured locally using a standardized assay.
Serum lipid, lipoprotein, and creatinine concentrations were
centrally determined at the laboratory of the Helsinki Univer-
sity Hospital from early morning blood samples. As partici-
pants had type 1 diabetes, fasting was not required, but
light breakfast was allowed to prevent or treat hypogly-
caemia. The serum creatinine concentration was used to cal-
culate eGFR [23]. Serum hsCRP concentration was measured
by immunoassay (Modular analyzer, Roche, Indianapolis,
USA). The attending physician recorded information on the
participant’s current medication use and diabetes complica-
tions on a standardized form. Acute myocardial infarction,
coronary bypass, stroke, amputation, and peripheral vascular
disease were coded as hard cardiovascular event. Retinal laser
treatment was an indication of severe diabetic retinopathy.
Insulin dose was self-reported. The method to obtain
self-reported data on physical activity has previously been
Table 1 – Basic characteristics and cardio-metabolic risk
factors of the total study sample.
n 902
CHO-to-fat ratio 1.17 (0.95–1.46)
Men (%) 44.1
Age (years) 47 ± 14
Diabetes duration (years) 28 (18–39)
Insulin dose (IU/kg) 0.55 (0.42–0.70)
Retinopathy (%) 28.4
eGFR (ml/min/1.73 m2) 101 (89–112)
Hard CV event (%) 11.2
BMI (kg/m2) 25.2 (23.0–27.8)
HbA1c (mmol/mol) 63 (55–71)
HbA1c (%) 7.9 (7.2–8.6)
SMBG mean 8.0 (6.8–9.3)
SMBG CV 0.42 (0.34–0.49)
SBP (mmHg) 135 (124–149)
DBP (mmHg) 76 (70–83)
hsCRP (mg/l) 1.1 (0.5–2.3)
Triglycerides (mmol/l) 0.91 (0.71–1.24)
Men n 398
WHR 0.93 (0.89–0.98)
BAI 23.5 (21.7–25.9)
Total CHOL (mmol/l) 4.40 (3.93–5.00)
Non-HDL CHOL (mmol/l) 2.90 (2.43–3.45)
HDL-CHOL (mmol/l) 1.49 (1.24–1.77)
HDL3-CHOL (mmol/l) 0.76 (0.61–0.91)
Women n 504
WHR 0.83 (0.79–0.87)
BAI 28.6 (25.7–32.1)
Total CHOL (mmol/l) 4.63 (4.11–5.15)
Non-HDL CHOL (mmol/l) 2.87 (2.40–3.33)
HDL-CHOL (mmol/l) 1.72 (1.44–2.03)
HDL3-CHOL (mmol/l) 0.75 (0.63–0.93)
Data are presented as median (interquartile range), frequency, or
mean ± standard deviation. CHO-to-fat ratio, calculated from per-
centages of energy derived from carbohydrates and fats; eGFR,
estimated glomerular filtration rate; Hard CV event, hard cardio-
vascular event; SMBG, self-monitored blood glucose; CV, coefficient
of variation; SBP, systolic blood pressure; DBP, diastolic blood
pressure; hsCRP, high-sensitivity C-reactive protein; WHR, waist-
to-hip ratio; BAI, body adiposity index; CHOL, cholesterol.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 8 1 8 3published [24]. In short, participants retrospectively reported
the frequencies, average durations, and intensities of 21 com-
mon leisure-time physical activities over the past 12 months.
From these reports, we calculated the metabolic equivalent of
task hours (METh) by multiplying the duration of the activity
by the activity- and intensity-specific metabolic equivalent.
The METh was treated as a continuous variable in the multi-
variable models.
2.2. Dietary intake
The methods to study dietary intake, in the FinnDiane Study,
have previously been described [4]. Briefly, at the study visit
participants were asked to complete a validated diet ques-
tionnaire [25]. Upon returning the questionnaire, participants
were sent a 3-day diet record. The allocated 3 days covered
two weekdays and one weekend day, and continuation of
habitual dietary practices was emphasised. The recording
was repeated after a 2–3 months’ interval with the aim at
obtaining a total of 6-day recording with some seasonal vari-
ation. AivoDiet software (version 2.0.2.3, AIVO, Turku, Fin-
land) was used to calculate energy and nutrient contents of
the participants’diets, as reported in the records. Mean nutri-
ent intakes from either 3-day (if only available) or 6-day
record were calculated. In the same record, participants also
reported self-monitored blood glucose (SMBG) values. From
these reports, mean and coefficient of variation (CV, standard
deviation divided by mean) of the measured values were cal-
culated for each participant.
For investigating the association between low-
carbohydrate intake and health, we took two separate
approaches. First, in order to utilise the data from the whole
population, we calculated a carbohydrate-to-fat ratio using
the percentages of energy (E%) derived from carbohydrates
and fats. The higher the ratio, the higher the carbohydrate
intake in relation to fat intake. This ratio was used as a con-
tinuous variable in the analyses. Second, based on the calcu-
lated carbohydrate intake, individuals with low carbohydrate
intakes (<130 g/day or <26 E%, as described in the paper by
Feinman et al. [17]) were identified. These individuals were
compared to sex-, diabetes duration- and eGFR-matched
controls, selected from a pool of participants in the highest
quintiles of carbohydrate intakes (>253 g/day or >48 E%). This
matching was done to ensure that the two populations would
be as similar as possible, so that potential differences in these
variables would not obscure the observations.
2.3. Statistical analyses
All analyses were conducted using IBM SPSS Statistics for
Windows, Version 22.0 (IBM Corp, Armonk, NY, USA), and
alpha value was set to 5% (two-tailed test). Means ± standard
deviations, medians (interquartile ranges), and frequencies
(%) were used to describe the study sample in normally dis-
tributed, non-normally distributed, and categorical observa-
tions, respectively. The between-group comparisons, in
these respective variables, were conducted with independent
samples t-test, Mann-Whitney U test, and Chi-squared test.
Multivariable generalized linear regression analysis was
applied when investigating the association betweencarbohydrate intake (either the carbohydrate-to-fat ratio or
the low-carbohydrate status) and the cardio-metabolic risk
factors. Models were adjusted for a number of background
variables (sex, diabetes duration, eGFR, insulin dose, physical
activity, BMI), medication related to the given outcome, and a
number of dietary variables (energy, alcohol, fibre) considered
important for the outcomes of interest. Data from men and
women were analysed together, except in case of variables
with known sex differences (e.g. waist-to-hip ratio and
cholesterol).
3. Results
Data were available from 902 individuals (44% men; mean
± standard deviation age 47 ± 13 years) (Table 1). The median
BMI of the sample was 25.2 kg/m2 and HbA1c 63 mmol/mol
(7.9%). Mean (min, max) daily carbohydrate intakes of the
whole sample were 205 g (65 g, 482 g) and 42 E% (17 E%, 60 E
4 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 8 1 8%). Mean (min, max) daily fat intakes of the total population
were 79 g (28 g, 208 g) and 36 E% (20 E%, 61 E%).
3.1. Carbohydrate-to fat ratio
Based on the percentages of energy derived from carbohy-
drates and fats, there was a median (interquartile range)
carbohydrate-to-fat ratio of 1.17 (0.95–1.46). In the multivari-
able analyses, higher carbohydrate-to-fat ratio was
associated with higher variability of the SMBG, and higher
systolic and diastolic blood pressure (Table 2). In men and
women, higher carbohydrate-to-fat ratio was associated
with lower HDL3-cholesterol concentration. In men, higher
carbohydrate-to-fat ratio was additionally associated with a
lower waist-to-hip ratio, while in women it was associated
with lower total and HDL-cholesterol concentration. Dietary
carbohydrate-to-fat ratio was not associated with BMI, body
adiposity index, glycaemic control, or the concentrations of
hsCRP, triglycerides, and non-HDL cholesterol.
3.2. Low-carbohydrate intake vs. higher carbohydrate
intake
Low-carbohydrate diet (<130 g/day or <26 E%) was endorsed
by 69 (7.6%) individuals. In all, 69 sex-, diabetes duration-,
and eGFR-matched controls with higher carbohydrate intake
were identified for the 69 individuals with low-carbohydrate
diet (Table 3). These two groups were comparable withTable 2 – The multivariable association between carbohydrate-t
B
Men and women
Body mass index 0.111
HbA1c 0.845
SMBG mean 0.013
SMBG CV 0.041
Systolic blood pressure 4.334
Diastolic blood pressure 2.471
hsCRP 0.110
Triglycerides 0.052
Men
Waist-to-hip ratio 0.024
Body adiposity index 0.542
Total cholesterol 0.168
Non-HDL cholesterol 0.072
HDL-cholesterol 0.082
HDL3-cholesterol 0.067
Women
Waist-to-hip ratio 0.007
Body adiposity index 0.538
Total cholesterol 0.255
Non-HDL cholesterol 0.089
HDL-cholesterol 0.144
HDL3-cholesterol 0.121
SMBG, self-monitored blood glucose concentration; CV, coefficient of v
adjusted for sex, diabetes duration, eGFR, insulin dose, total energy int
mean, SMBG CV, SBP, DBP, hsCRP, and triglyceride analyses are addition
tionally adjusted for lipid lowering medication, and blood pressure a
Generalized linear regression.respect to age and complication status. Men with low
carbohydrate intakes had higher WHR, total cholesterol
concentration, non-HDL cholesterol concentration, and
HDL3-cholesterol concentration compared to men with
higher carbohydrate intakes. Women with lower carbohy-
drate intakes had lower BAI, and higher total, HDL-, and
HDL3-cholesterol concentrations.
Those in the low-carbohydrate group reported lower total
energy and fibre intake, but higher alcohol intake (Supple-
mentary Table 1). Instead, protein intake per body weight
was comparable between the two groups. In the multivariable
analyses, individuals with lower carbohydrate intakes had
lower BMI, lower variability of the SMBG values, and lower
diastolic blood pressure (Table 4). Men in the low-
carbohydrate group had higher total and non-HDL cholesterol
concentrations, while women had lower BAI and higher
HDL-cholesterol concentration.
4. Discussion
Adherence to a low-carbohydrate diet was not common, in
the current sample. Only 7.6% of the total population was
considered low-carbohydrate adherents, with carbohydrate
intakes below either 130 g/day or 26 E% [17]. Compared to
sex-, diabetes duration-, and eGFR-matched individuals with
higher carbohydrate intakes, those with low carbohydrate
intake had significantly lower BMI, had lower variability of
the SMBG values, and had lower diastolic blood pressure. Ino-fat ratio and cardio-metabolic risk factors.
95% Wald Confidence Interval P
0.867–0.645 0.774
1.623–3.313 0.502
0.345–0.370 0.945
0.016–0.065 0.001
1.188–7.480 0.007
0.725–4.217 0.006
0.450–0.231 0.528
0.166–0.061 0.368
0.046 to 0.002 0.029
0.358–1.442 0.238
0.418–0.081 0.186
0.313–0.169 0.558
0.196–0.032 0.158
0.126 to 0.009 0.023
0.023–0.010 0.416
0.746–1.822 0.412
0.476 to 0.034 0.024
0.290–0.112 0.386
0.262 to 0.027 0.016
0.181 to 0.060 <0.001
ariation, hsCRP, high-sensitivity C-reactive protein. All models are
ake, fibre intake, alcohol intake, and physical activity. HbA1c, SMBG
ally adjusted for BMI. Moreover, lipid and hsCRP analyses are addi-
nalyses are additionally adjusted for antihypertensive medication.
Table 3 – Basic characteristics and cardio-metabolic risk factors of the study sample divided by the carbohydrate intake
status.
Low-CHO diet High-CHO diet
n 69 n 69 P
CHO-to-fat ratio 0.75 (0.60–0.91) 1.59 (1.48–1.87) <0.001
Men (%) 31.9 31.9 1.000
Age (years) 51 ± 11 49 ± 14 0.262
Diabetes duration (years) 35 ± 14 32 ± 14 0.325
Insulin dose (IU/kg) 0.52 (0.42–0.67) 0.56 (0.40–0.71) 0.472
Retinopathy (%) 41.2 32.4 0.374
eGFR (ml/min/1.73 m2) 92 ± 17 96 ± 15 0.163
Hard CV event (%) 10.1 17.6 0.226
BMI (kg/m2) 25.0 (23.4–27.9) 25.6 (23.6–29.6) 0.311
HbA1c (mmol/mol) 60 (53–72) 65 (55–72) 0.208
HbA1c (%) 7.6 (7.0–8.7) 8.1 (7.2–8.7) 0.208
SMBG mean (mmol/l) 8.2 (6.8–9.8) 7.7 (6.8–9.5) 0.681
SMBG CV (mmol/l) 0.39 ± 0.13 0.42 ± 0.12 0.138
SBP (mmHg) 139 (127–151) 139 (129–150) 0.696
DBP (mmHg) 75 ± 9 78 ± 9 0.101
hsCRP (mg/l) 1.1 (0.5–2.3) 1.2 (0.5–2.6) 0.939
TG (mmol/l) 0.95 (0.69–1.25) 0.97 (0.68–1.30) 0.995
Men n 22 n 22
WHR 0.96 ± 0.07 0.92 ± 0.06 0.040
BAI 25.0 ± 4.8 24.1 ± 2.9 0.463
Total CHOL (mmol/l) 4.79 (3.99–5.27) 4.27 (3.76–4.64) 0.010
Non-HDL CHOL (mmol/l) 3.28 ± 0.89 2.79 ± 0.44 0.033
HDL-CHOL (mmol/l) 1.71 ± 0.57 1.48 ± 0.50 0.163
HDL3-CHOL (mmol/l) 0.91 ± 0.26 0.72 ± 0.23 0.022
Women n 46 n 46
WHR 0.85 ± 0.06 0.85 ± 0.07 0.962
BAI 29.3 ± 4.5 32.3 ± 5.4 0.004
Total CHOL (mmol/l) 4.89 (4.49–5.51) 4.46 (3.84–4.88) 0.002
Non-HDL CHOL (mmol/l) 3.08 ± 0.91 2.89 ± 0.68 0.277
HDL-CHOL (mmol/l) 1.96 ± 0.56 1.55 ± 0.36 <0.001
HDL3-CHOL (mmol/l) 0.86 ± 0.23 0.73 ± 0.23 0.009
Data are presented as median (interquartile range), frequency, or mean ± standard deviation. Low-CHO diet, low-carbohydrate diet, <130 g/day
or <26 E%; High-CHO diet, higher carbohydrate diet, sex-, diabetes duration- and eGFR-matched controls identified from a pool of participants
in the highest quintile of carbohydrate intake (>253 g/day or > 48 E%); CHO-to-fat ratio, calculated from percentages of energy derived from
carbohydrates and fats; eGFR, estimated glomerular filtration rate; Hard CV event, hard cardiovascular event; SMBG, self-monitored blood
glucose concentration; CV, coefficient of variation; SBP, systolic blood pressure; DBP, diastolic blood pressure; hsCRP, high-sensitivity C-reactive
protein; TG, triglycerides; WHR, waist-to-hip ratio; BAI, body adiposity index; CHOL, cholesterol.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 8 1 8 5women with lower carbohydrate intakes, lower BAI and
higher HDL-cholesterol concentrations were observed, while
in men low-carbohydrate diet was associated with higher
total and non-HDL cholesterol levels. In thewhole population,
we investigated the association between dietary
carbohydrate-to-fat ratio and cardio-metabolic risk factors.
In these analyses, higher carbohydrate intake in relation to
fat was associated with higher blood glucose variability and
higher systolic and diastolic blood pressure, and lower
HDL3-cholesterol concentrations. Furthermore, in men,
higher carbohydrate-to-fat ratio was associated with lower
waist-to-hip ratio, and in women it was associated with lower
total and HDL-cholesterol concentrations.
The association between adherence to a low-carbohydrate
diet and glycaemic control, in type 1 diabetes, has been
reported in a number of previous papers. In an online survey
including 316 children and adults with type 1 diabetes, who
voluntarily adhered to a low-carbohydrate diet, an average
HbA1c of 39 mmol/mol (5.7%) was reported [14]. This excep-tional glycaemic control was achieved with an average daily
carbohydrate intake of 36 ± 15 g, without an increase in the
frequency of hypoglycaemias. In another observational study,
the mean HbA1c of 11 adults with type 1 diabetes, following a
diet with <55 g of carbohydrates per day, was 35 mmol/mol
(5.4%) [21]. Nielsen et al described their observations from a
total of 48 individuals with type 1 diabetes who took part in
an educational course to reduce daily carbohydrate intake
to 75 g per day [26]. Three months after the start of the
course, a significant reduction in HbA1c was reported. More-
over, unlike in those not adherent, a significant improvement
in glycaemic control was evident among the continuously
adherent participants also four years after the course. Ran-
domized trials with low-carbohydrate diets in type 1 diabetes
are scarce. In one small study, 10 subjects with type 1 diabetes
were randomly assigned either to a standard carbohydrate
counting course or to the same course with additional
instructions to achieve andmaintain a diet with a daily carbo-
hydrate intake of 50–75 g [27]. At the end of the 12-week
Table 4 – The multivariable analyses investigating the association between carbohydrate intake status and cardio-metabolic
risk factors.
Low-CHO diet n 69 High-CHO diet n 69
Mean 95% CI Mean 95% CI P
Men and women
BMI (kg/m2) 25.6 24.1–26.8 27.8 26.5–29.1 0.030
HbA1c (mmol/mol) 61.4 58.0–64.8 64.6 60.8–68.3 0.278
SMBG mean (mmol/l) 8.3 7.7–8.8 8.3 7.7–8.9 0.902
SMBG CV (mmol/l) 0.38 0.34–0.42 0.45 0.41–0.49 0.030
SBP (mmHg) 136 132–141 142 137–147 0.188
DBP (mmHg) 74 72–77 79 76–81 0.048
hsCRP (mg/l) 1.9 1.4–2.5 1.9 1.3–2.5 0.962
Triglycerides (mmol/l) 1.18 1.02–1.34 1.03 0.85–1.20 0.277
Men
WHR 0.95 0.93–0.98 0.95 0.92–0.99 0.969
BAI 25.3 23.5–27.2 24.9 22.4–27.4 0.813
Total CHOL (mmol/l) 5.08 4.68–5.48 4.00 3.46–4.55 0.007
Non-HDL CHOL (mmol/l) 3.42 3.12–3.72 2.71 2.26–3.15 0.021
HDL-CHOL (mmol/l) 1.67 1.46–1.88 1.58 1.29–1.86 0.658
HDL3-CHOL (mmol/l) 0.89 0.80–0.98 0.82 0.69–0.96 0.500
Women
WHR 0.85 0.82–0.87 0.86 0.83–0.88 0.692
BAI 29.0 27.1–31.0 33.1 31.1–35.2 0.014
Total CHOL (mmol/l) 4.90 4.57–5.23 4.52 4.20–4.84 0.162
Non-HDL CHOL (mmol/l) 3.00 2.74–3.25 3.03 2.77–3.28 0.884
HDL-CHOL (mmol/l) 1.91 1.73–2.10 1.54 1.36–1.73 0.014
HDL3-CHOL (mmol/l) 0.85 0.76–0.94 0.76 0.67–0.85 0.199
Data are presented as adjusted means and standard errors. Low-CHO diet, low-carbohydrate diet, <130 g/day or <26 E%; High-CHO diet, higher
carbohydrate diet, sex-, diabetes duration- and eGFR-matched controls identified from a pool of participants in the highest quintile of car-
bohydrate intake (>253 g/day or >48 E%); SMBG, self-monitored blood glucose concentration; CV, coefficient of variation; SBP, systolic blood
pressure; DBP, diastolic blood pressure; hsCRP, high-sensitivity C-reactive protein; WHR, waist-to-hip ratio; BAI, body adiposity index; CHOL,
cholesterol. All models are adjusted for sex, diabetes duration, eGFR, insulin dose, total energy intake, fibre intake, alcohol intake, and physical
activity. HbA1c, SMBG mean, SMBG CV, SBP, DBP, hsCRP, and triglyceride analyses are additionally adjusted for BMI. Moreover, lipid and hsCRP
analyses are additionally adjusted for lipid lowering medication, and blood pressure analyses are additionally adjusted for antihypertensive
medication. Generalized linear regression.
6 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 8 1 8intervention HbA1c, in the carbohydrate restriction group,
was significantly reduced from a mean of 63 to 55 mmol/mol
(7.9 to 7.2%), with no change in the control group. Albeit
weight loss was not promoted, in that study, a 6.3% and
0.5% weight reduction was observed in the intervention and
control group, respectively. In the current study, we also
looked at the relation between carbohydrate intake and a
number of variables related to body weight. Here we noticed
that individuals with higher carbohydrate intakes had higher
BMI, and women with high carbohydrate intakes had higher
BAI compared to those adhering to a lower carbohydrate diet.
Contrary to these observations, higher carbohydrate intake in
relation to fat was in men associated with lower waist-to-hip
ratio. As carbohydrate restriction is sometimes used as a
weight-loss method [28], our cross-sectional observations
could indicate that carbohydrate restriction is more prevalent
among men with a desire to lose weight.
Intensified insulin therapy, in the Diabetes Control and
Complications Trial, resulted in improved glycaemic control,
but was only accomplished by simultaneous increase in the
risk of hypoglycaemia [13]. It has been suggested that improv-
ing glycaemic control without increasing the risk of hypogly-
caemia may only be achieved by reducing glycaemic
variability [29]. Of interest, adhering to a low-carbohydrate dietand diets with lower carbohydrate-to-fat ratio, in the current
study, were associated with reduced variability in the blood
glucose measurements. This could be of clinical importance
as large blood glucose variability has been suggested to play
a key role in the pathology of end-organ damage in diabetes
[30]. Reduced glycaemic variability has also been reported in
other studies of low-carbohydrate diets [15,16,21]. In addition
to improved glycaemia and reduced glycaemic variability,
low-carbohydrate diets have been associatedwith longer time
spent in euglycaemia, and less time in hypoglycaemia [15].
Besides their effects on glycaemia, low-carbohydrate diets
have also been associated with improved HDL-cholesterol
levels [14,25,28,31], lower triglyceride concentrations
[14,25,28,31], and reduced blood pressure [31]. The current
observations with lower blood pressure and higher
HDL-cholesterol concentration, associated with diets lower
in carbohydrates in relation to fats, are in line with these
reports. However, these beneficial effects are sometimes
opposed by observations of increased total and/or
LDL-cholesterol concentrations [14,21,31], which have raised
concern of long-term safety of low-carbohydrate diets [21].
In the current study, higher total cholesterol and non-HDL
cholesterol concentrations were observed in 22 men in the
low-carbohydrate arm. Instead, in women, higher
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 8 1 8 7carbohydrate-to-fat ratio was associated with lower total
cholesterol levels. However, this association seemed to be
explained by lower HDL-cholesterol concentrations, instead
of lower non-HDL cholesterol concentrations. In previous
studies, high fat intake has shown to give rise to the larger-
sized LDL-cholesterol particles, which are sometimes consid-
ered less atherogenic than the smaller and denser particles
[32,33]. Larger LDL-cholesterol particles can, however, also
be associated with increased coronary disease risk, particu-
larly in the setting of normal or low triglyceride levels [32].
Longitudinal trials are, therefore, needed to assess the
cardio-metabolic effects of low-carbohydrate diets.
Considering the low number and the small size of the pub-
lished studies in this field, a large sample of well-defined indi-
viduals with type 1 diabetes is a major strength of the current
study. However, there are also important limitations to be
acknowledged. The study is cross-sectional, and can therefore
only reveal associations between dietary intake and health
variables. Despite considering a number of confounders in
the analyses, residual confounding from variables not
accounted for may remain. As participants were volunteers,
some selection bias may also be evident. It is likely that
individuals more interested in health and diet are over-
represented in the current sample. Due to the changes in
cardiovascular risk factors and dietary intake related to
emerging diabetic kidney disease, we excluded those with
eGFR < 60 ml/min/1.73 m2. Therefore, the current observa-
tions may only be generalized to individuals with type 1
diabetes and fairly well preserved renal function. The assess-
ment of dietary intake with a self-reported record has its
limitations, such as over- and under-reporting of food items
generally considered healthy and unhealthy, respectively.
Whether such misreporting would have affected the
macronutrient proportions of the diets, is not known. While,
with a 417 g (or 43 E%) range, we were able to capture great
diversity in the carbohydrate intake, the current results may
only be applied within the observed range, and not in higher
or lower carbohydrate intakes. With the methods applied,
we were not able to distinguish between low and high gly-
caemic index carbohydrates. Due to this shortcoming, the
results only reflect the total carbohydrate intake. It should also
be noted that using the grams/day criteria (<130 g/day) for a
low-carbohydrate diet, identifies not only those attempting
to adhere to a low-carbohydrate diet, but also any light eaters.
Women, for example, on average eat less thanmen. Moreover,
with longer diabetes duration, emergence of various health
concerns can affect dietary intake. By taking sex, diabetes
duration and eGFR into account, we ensured that the two
groupswere comparablewith regards to these basic character-
istics. Finally, while the number of low-carbohydrate
adherents was modest, in the current study, by using the
carbohydrate-to-fat ratio we were able to include the whole
population in the analyses, and to see whether the relative
distribution of the two macronutrients played any role in the
health markers.
In conclusion, lower carbohydrate intake and lower dietary
carbohydrate-to-fat ratio were associated with a number of
beneficial metabolic observations, such as lower variability
in the blood glucose concentrations, lower blood pressure,
and higher HDL-cholesterol concentration. However, in menadherence to low-carbohydrate diet was associated with
higher total and non-HDL cholesterol concentrations, and
higher waist-to-hip ratio. Large randomized controlled trials
are needed to reveal the long-term risks and benefits of
low-carbohydrate diets in type 1 diabetes.
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